Early and sustained clopidogrel therapy worth it in Europe

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1512, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early etanercept worth it in RA therapy sequence

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

In Support of Early Surgery for Hip Fractures Sustained by Elderly Patients Taking Clopidogrel: A Retrospective Study

By Chechik Ofir   Amar Eyal   Khashan Morsi   Kadar Assaf   Rosenblatt Yishai   Maman Eran  

Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. : 63-68

Adis International

Access to resources Recommend Favorite

Clopidogrel consistently outshines aspirin in Europe

By  

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

HPV vaccine worth a shot in Europe

By  

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

HPV vaccine worth a shot in Europe

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite